Home
Issues
Search
FR
|
HY
|
EN
|
RU
Home
Search : G
Search
Result : 349
«
1
2
3
4
5
6
7
»
Chronic coccygodynia
Chronic coccygodynia is defined as pain in the c occyx which has been present for more than six months and which is aggravated by sitting down and/or rising. Although the diagnosis is primarily...
Thibault Riant,
Cristina Graur.
June 2025, page 45
Chronic pelvi-perineal pain: 10 key messages
Éric Bautrant.
June 2025, page 75
Sporotrichoid tufted angioma
Yousef Almheirat,
Mounia Benkaraache,
Houda Talbi,
Nassiba Zarrouki,
Siham Dikhaye,
Nada Zizi.
June 2025, page 78
Living with… Kawasaki disease
Alexandre Belot,
Raphaël Darbon.
June 2025, page 87
Chronic lymphocytic leukaemia
Carolyne Croizier,
Romain Guièze,
Olivier Tournilhac.
June 2025, page 91
Emergency treatment of acute cerebral ischemia
Five complementary strategies increase disability - and dependency - free survival after acute cerebral ischemia: - stroke unit care, independent on age, severity, type of stroke, and treatment; -...
Didier Leys,
Charlotte Cordonnier.
November 2025, page 6
Management of neuropathic pain: Don’t lose hope!
Neuropathic pain represents a major challenge in the diagnosis and initiation of treatment. This article provides an overview of its definition, epidemiology, and common etiologies. Current...
Emmanuel Nolot,
Xavier Moisset,
Nadine Attal.
November 2025, page 12
The skin, mirror of the soul: an anthropology of tattoos
Philippe Charlier.
November 2025, page 22
Special features of ANCA-associated vasculitides
Necrotizing vasculitis associated to antineutrophil cytoplasmic antibodies (ANCA) are one of the subgroups of vasculitis affecting small-sized vessels. Fibrinoid necrosis of the vascular wall is...
Loïc Guillevin.
November 2025, page 27
Epidemiology and risk factors of ANCAassociated vasculitides
ANCA-associated vasculitides (AAV) are a group of small-vessel vasculitides including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with...
Lucas Pacoureau,
Maxime Beydon,
Benjamin Terrier,
Yann Nguyen.
November 2025, page 34
Recent developments in the treatment of ANCA-associated vasculitides
The treatment of antineutrophil cytoplasm antibody-associated (ANCA) vasculitis is based on induction therapy to achieve remission, followed by maintenance therapy to prevent relapse. Management...
Xavier Puéchal.
November 2025, page 43
Towards more targeted therapies in the treatment of ANCA-associated vasculitides
The treatment of ANCA-associated vasculitides (AAV) is based on therapeutic strategies that achieve remission and significantly reduce the risk of relapse in most cases over the medium term....
Alexandre Karras.
November 2025, page 49
ANCA-associated vasculitides: 10 key messages
Benjamin Terrier.
November 2025, page 54
Giant hepatic hydatid cyst
Ayoub Boubekri,
Aissa Ismail,
Mustapha Bensghir.
November 2025, page 59
Functional neurological disorders
Functional Neurological Disorders (FND) are symptoms associated with dysfunctions in brain networks, often triggered by physical and/or psychological traumatic factors in vulnerable individuals....
Béatrice Garcin.
November 2025, page 60
Living with… the burden of obesity
David Nocca.
November 2025, page 65
Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?
Psychedelics, long marginalized, are now gaining renewed interest in psychiatry for their therapeutic potential. Substances
like psilocybin, LSD, and MDMA are being studied for treating...
Michel Sabé,
Federico Seragnoli,
Louise Penzenstadler,
Gabriel Thorens.
November 2025, page 69
Genital hemorrhage in women
Rosa Montero Macias,
Cyrille Huchon,
Arnaud Fauconnier.
November 2025, page 75
Press review
Agathe Ribéreau-Gayon.
April 2026, page 6
Tobacco in films and smoking among young people
The presence of tobacco in films and TV series remains widespread, despite its proven impact on the initiation of smoking among young people. In addition to films, platforms massively distribute...
Gérard Peiffer ,
Nathalie Lajzerowicz ,
Olivier Galera ,
Jean Perriot ,
Emmanuel Ricard ,
Karine Gallopel-Morvan .
April 2026, page 8
Dying, but not too soon: analysis of changes in life expectancy
Philippe Charlier .
April 2026, page 14
Is nature in the city beneficial to health?
Mathilde Pascal ,
Philippe Pirard .
April 2026, page 18
Venous diseases of the liver: what are we talking about?
Vascular diseases of the liver include damage to arterial and venous vessels, both hepatic and perihepatic. The main venous forms are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT) and...
Audrey Payancé ,
Juliette Soret-Dulphy .
April 2026, page 22
When should vascular liver disease be considered?
Vascular liver diseases (VLD) are rare and their diagnosis can be difficult and late, leading to a delay in treatment. Diagnosis is most often multidisciplinary, involving primarily the clinician...
Jérôme Dumortier ,
Maxime Ronot ,
Aurélie Beaufrère .
April 2026, page 25
Budd-Chiari syndrome
Budd-Chiari syndrome is a rare condition characterized by obstruction of hepatic venous drainage, ranging from hepatic venules to the terminal part of the inferior vena cava. A thorough etiological...
Magdalena Meszaros ,
Christophe Bureau .
April 2026, page 31
Small liver vessels disorders
Small liver vessels disorders are a heterogeneous group of rare diseases that can affect the portal venules, the hepatic sinusoids, the centri-lobular veins, or the hepatic arteries. The most...
Lucile Moga ,
Pierre-Emmanuel Rautou .
April 2026, page 40
Portal vein thrombosis and mesenteric venous ischemia
Portal vein thrombosis (PVT) in the absence of underlying chronic liver disease is a rare disease and is frequently associated with prothrombotic factors. In patients with cirrhosis, the frequency...
Cyprien Gayat ,
Alexandre Nuzzo ,
Laure Elkrief .
April 2026, page 44
Special features of anticoagulant treatment in vascular liver diseases
Anticoagulants play a major role in the management of vascular liver diseases (VLD). However, their use is challenging due to portal hypertension and thrombocytopenia, frequently observed in these...
Emmanuelle De Raucourt ,
Imen Ben Salah ,
Juliette Gay .
April 2026, page 52
Vein and sinusoidal diseases of the liver: 10 key messages
Aurélie Plessie.
April 2026, page 60
High radial paralysis
Charlène Fraysse ,
Pierre Lesage .
April 2026, page 63
Allergic contact dermatitis to argan oil
Ouissal Hormi ,
Nassiba Zerrouki ,
Nada Zizi .
April 2026, page 66
Sweet’s syndrome revealing pulmonary sarcoidosis
Zakaria Haddadi ,
Yousef Almheirat ,
Nada Zizi ,
Mohammed Leknani ,
Siham Nasri ,
Imane Kamaoui ,
Imane Skiker .
April 2026, page 67
Viral hepatitis and pregnancy
The event of pregnancy, the risks of obstetrical complications and vertical transmission will vary according to the type of viral hepatitis. Hepatitis A is transmitted via feacal-oral transmisson,...
Imane Ben M'Barek ,
Jeanne Sibiude ,
Élise Bouthry .
April 2026, page 71
Methods of cerebral stimulation in psychiatry
Psychiatric disorders are a frequent reason for consultation, accounting for 15% of general medical visits. Some patients have severe disorders, meaning they have a significant impact on their...
Océane Dufrenne ,
Charles Laidi .
April 2026, page 76
Borderline personality disorder
Borderline Personality Disorder (BPD) is common, affecting 2 to 6 % of the general population, with a high prevalence in psychiatric settings. It is characterized by emotional, relational...
Deborah Ducasse ,
Émilie Olié .
April 2026, page 81
Living with… a migraine
Sabine Debremaeker.
April 2026, page 86
Acute inflammatory polyradiculoneuritis (Guillain-Barré syndrome)
Guillaume Nicolas ,
Djillali Annane ,
David Orlikowski .
April 2026, page 88
Mandatory vaccination against meningococcus B: critical analysis of the arguments put forward by the CS-CNGE
Samy Taha,
Ala-Eddine Deghmane,
Muhamed-Kheir Taha.
September 2026, page 6
Healing Gods in India
Philippe Charlier,
Saudamini Deo.
September 2026, page 10
Metabolic dysfunction associated steatohepatitis, epidemiology and definitions: from steatosis to cirrhosis
A recent change in terminology proposed by scientific societies replaces the term NAFLD (non-alcoholic fatty liver disease) with the term MASLD (metabolic dysfunction associated steatotic liver...
Raluca Pais.
September 2026, page 14
Diagnostic approach for metabolic dysfunction associated steatotic liver disease
Metabolic dysfunction associated steatotic liver disease (MASLD) is a systemic disease affecting the liver. The diagnostic approach consists of the identification of hepatic steatosis, the...
Lucia Parlati,
Charlotte Mouliade,
Stanislas Pol.
September 2026, page 19
FIB-4: a simple blood test to identify patients at risk of liver complications
Jérôme Boursier,
Frédéric Oberti.
September 2026, page 24
Current and future medical treatments for metabolic dysfunction-associated steatohepatitis
Drug treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) is undergoing a revolution. The fight against cardiovascular risk factors, the optimization of the treatment of...
Rodolphe Anty,
Marwin A Farrugia.
September 2026, page 26
The role of bariatric surgery and endoscopy in the management of MASLD
The epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD), amplified by shifting dietary habits and increasing sedentary lifestyles, has elevated metabolic...
Nawel Chouraqui,
Guillaume Lassailly.
September 2026, page 36
Steatosis and steatohepatitis: a risk factor for complications after liver resection
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), have become common clinical conditions in...
Karim Boudjema,
Fabien Robin,
Heithem Jeddou,
Pauline Houssel-Debry.
September 2026, page 40
Metabolic dysfunction-associated steatotic liver diseases: 10 key messages
Catherine Buffet.
September 2026, page 45
Acquired hemophilia A
Louis Hebraud,
Olivier Fain,
Ambroise Le Pogam.
September 2026, page 48
Living with… a stroke
Thomas de Broucker.
September 2026, page 54
Inflammatory response
Sylvain Audia,
Guillaume Brenac,
Bernard Bonnotte.
September 2026, page 59
«
1
2
3
4
5
6
7
»